Next Article in Journal
Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
Next Article in Special Issue
The Synthesis and Preclinical Investigation of Lactosamine-Based Radiopharmaceuticals for the Detection of Galectin-3-Expressing Melanoma Cells
Previous Article in Journal
Simultaneous Determination of Glibenclamide and Silymarin Released from Chitosan Microparticles by HPLC-ESI-MS Technique: Method Development and Validation
Previous Article in Special Issue
Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(10), 2166; https://doi.org/10.3390/pharmaceutics14102166
Action Date Notes Link
article pdf uploaded. 11 October 2022 15:25 CEST Version of Record https://www.mdpi.com/1999-4923/14/10/2166/pdf-vor
article xml file uploaded 25 October 2022 08:59 CEST Original file -
article xml uploaded. 25 October 2022 08:59 CEST Update https://www.mdpi.com/1999-4923/14/10/2166/xml
article pdf uploaded. 25 October 2022 08:59 CEST Updated version of record https://www.mdpi.com/1999-4923/14/10/2166/pdf
article html file updated 25 October 2022 09:01 CEST Original file -
article html file updated 28 February 2023 17:35 CET Update -
article html file updated 1 March 2023 20:53 CET Update https://www.mdpi.com/1999-4923/14/10/2166/html
Back to TopTop